Industry Leaders Leica Biosystems, Indica Labs and Lunit Partner to Develop AI-Powered Computational Pathology Assays for PD-L1 and Emerging Biomarkers
recent articles
VISTA, California, ALBUQUERQUE, New Mexico, and SEOUL, South Korea — May 26, 2026 — Leica Biosystems, a Danaher company and a global leader in end-to-end anatomic and digital pathology solutions, and Indica Labs, a global leader in...
Pictor Labs, the UCLA spinout behind a suite of AI-powered virtual staining tools, used USCAP 2026, the annual pathology meeting in Los Angeles, to debut a dedicated on-premises hardware system that runs its full product line, including...
ROCHESTER, Minn. — Mayo Clinic Digital Pathology (MCDP) is advancing efforts to build an integrated innovation ecosystem that supports the future of pathology across clinical care and research. The work reflects Mayo Clinic’s broader...
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc., a leader in artificial intelligence and precision medicine, today announced the clinical launch of the ArteraAI Prostate Test (mHSPC). The CLIA-certified and CAP-accredited prognostic test will...
Grundium Acquires Visiopharm: The combined platform brings together digital slide scanning and AI-driven precision pathology software to accelerate accessible and scalable adoption of precision diagnostics TAMPERE, FI AND COPENHAGEN, DK...
Taylor & Francis is pleased to invite you to submit your work to an upcoming Article Collection on “Breast cancer biomarkers in diagnostic and translational pathology” in the journal Breast Cancer: Targets and Therapy. This Article...































